{
     "PMID": "9076758",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19970612",
     "LR": "20131121",
     "IS": "0028-3908 (Print) 0028-3908 (Linking)",
     "VI": "35",
     "IP": "12",
     "DP": "1996",
     "TI": "Chronic treatment with antipsychotic drugs does not alter G protein alpha or beta subunit levels in rat brain.",
     "PG": "1785-91",
     "AB": "Groups of rats received once daily subcutaneous treatments for 22 days with haloperidol (0.5 mg/kg), clozapine (20 mg/kg), SCH 23390 (0.2 mg/kg) or vehicle. Quantitative immunoblots for Gi alpha 1, Gi alpha 2, G(o alpha), Gs alpha (45 kD), G beta 35 and G beta 36 were performed on membranes from the following brain regions: striatum, nucleus accumbens, substantia nigra, ventral tegmental area (VTA), prefrontal cortex and hippocampus (CA1). No significant alterations were found in the levels of any of these G protein subunits, in any brain region in treated vs control rats.",
     "FAU": [
          "Meller, E",
          "Bohmaker, K"
     ],
     "AU": [
          "Meller E",
          "Bohmaker K"
     ],
     "AD": "New York University Medical Center, Department of Psychiatry, NY 10016, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "NS-23618/NS/NINDS NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "England",
     "TA": "Neuropharmacology",
     "JT": "Neuropharmacology",
     "JID": "0236217",
     "RN": [
          "0 (Antipsychotic Agents)",
          "0 (Benzazepines)",
          "0 (Macromolecular Substances)",
          "EC 3.6.1.- (GTP-Binding Proteins)",
          "J60AR2IKIC (Clozapine)",
          "J6292F8L3D (Haloperidol)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antipsychotic Agents/*pharmacology",
          "Benzazepines/*pharmacology",
          "Brain/drug effects/*metabolism",
          "Cell Membrane/metabolism",
          "Clozapine/*pharmacology",
          "Electrophoresis, Polyacrylamide Gel",
          "GTP-Binding Proteins/chemistry/isolation & purification/*metabolism",
          "Haloperidol/*pharmacology",
          "Macromolecular Substances",
          "Male",
          "Organ Specificity",
          "Rats",
          "Rats, Sprague-Dawley",
          "Reference Values"
     ],
     "EDAT": "1996/01/01 00:00",
     "MHDA": "1996/01/01 00:01",
     "CRDT": [
          "1996/01/01 00:00"
     ],
     "PHST": [
          "1996/01/01 00:00 [pubmed]",
          "1996/01/01 00:01 [medline]",
          "1996/01/01 00:00 [entrez]"
     ],
     "AID": [
          "S0028390896001190 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neuropharmacology. 1996;35(12):1785-91.",
     "term": "hippocampus"
}